The 779 reported deaths give a two-year case fatality rate of 6.6%. Some 243 outbreaks or clusters were detected, 150 of which were linked to travel-associated infections. As in previous years, the overall main method of diagnosis was by urinary antigen detection and the proportion of cases diagnosed by culture remained low at 8.8%, although isolation rates by country ranged from under 1% to over 40%.
Introduction
Legionnaires' disease is a bacterial infection characterised by atypical pneumonia. It is caused by Legionella bacteria which live in water and other moist environments, and are ubiquitous in the natural environment. When aerosolised and inhaled they can cause infection. Aerosol-generating outlets that are commonly associated with cases of Legionnaires' disease include wet cooling systems, water systems and spa pools [2] .
In 1986, collaborations across Europe were established to share knowledge about Legionella spp. and to monitor trends in this infection. This became known as the European Working Group for Legionella Infections (EWGLI), and it currently has 36 member countries. Every year EWGLI requests a dataset from each participating country, to record the number and characteristics of the cases of Legionnaires' disease that were diagnosed in that country's residents during the preceding year. This allows for comparison of the disease between countries, the monitoring of trends within countries and for analysis of data at the European level.
Data from the years 1996 to 2006 have been published previously [1, [3] [4] [5] [6] [7] [8] . This paper presents the dataset for the years 2007 and 2008.
Methods
The datasets requested from the countries contain epidemiological and microbiological information: the number of confirmed and presumptive cases, the number of deaths, the population base covered (in some countries, the institution collaborating with EWGLI only receives data for a region of the country), the method of diagnosis and the species and serogroup of any isolates obtained, age group and sex of the cases, category of exposure (nosocomial, travelor community-associated), countries of travel (where appropriate), and outbreaks by type, size and suspected source.
Cases are classified as confirmed or presumptive according to the EWGLI case definitions (a classification of 'diagnosis not known' is accepted according to national reporting criteria) [9] . In addition, each case is categorised by the activities they were engaged in during their incubation period and are recorded as 'travel', 'nosocomial' or 'community' infections. Each country defines nosocomial and community categories according to their national case definitions, whereas a European-wide case definition is used for travelassociated cases. If there is insufficient evidence to allocate a case to one of the categories (e.g. if a case spent part of their incubation period travelling and part in hospital), the case is classified as 'other'. If no exposure information is available, the case is classified as category 'not known'.
Incidence rates per million population are based on national population size, with the exception of three countries where regional incidence rates were reported in both years (Bulgaria, Lithuania and Russia), and in Romania where regional incidence rates were reported for 2008. It should be noted that these data may not be representative of the entire country if, for example, reporting is stronger in the region of the country which reports to this international scheme. Age-standardised rates are calculated from the number of cases in each age stratum and the underlying population denominator for the strata in each participant country.
The term 'outbreak' is mainly used to describe outbreaks in hospitals or community settings, and the term 'cluster' is mainly used for travel-associated cases to describe the association of more than one case with a hotel or other tourist accommodation site. Travelassociated clusters are defined as 'two or more cases associated with the same accommodation site within two years', based upon the definitions established by EWGLI's travel-associated surveillance scheme, EWGLINET [9] . All other clusters and outbreaks are defined independently by the country where the infection was acquired.
Results
In 2007, 5,907 cases were reported by 33 countries, and in 2008, 5,960 cases were reported by 34 countries (including Cyprus, who contributed data for the first time). In the 16 years for which this dataset has been collected, a total of 53,494 cases have been reported (Table 1 ).
Incidence rates
The overall incidence per million population was 11. Romania reporting only data from one region in that year. In all other countries, the area of each country covered by their datasets remained consistent across both years. The number of reported cases for both years was highest in France, Italy and Spain, although rates per million population were higher in some countries that had reported fewer cases (in 2007: Andorra, Denmark, Malta, the Netherlands and Switzerland; in 2008: Denmark, the Netherlands, Slovenia and Switzerland). Figure  1 ).
The case fatality ratio (CFR) remained stable across the two years: 391 deaths were reported in 2007 (CFR 6.6%) and 388 were reported in 2008 (CFR 6.5%).
Microbiology
EWGLI collaborators allocate a main method of diagnosis to each reported case, taking culture as the 'goldstandard' test. Over the two years, a total of 1,042 cases were diagnosed by isolation/culture (8.8%). The primary method of diagnosis used was urinary antigen detection (81.0%), and the method of diagnosis was unknown for 187 cases (1.6%) ( Table 3 ). This method of classifying the cases cannot take into account the fact that some will have had more than one method of diagnosis carried out, e.g. culture and urinary antigen detection or PCR and serology. In such cases the primary method is defined in the following order of preference for this analysis: culture, urinary antigen, serology, other.
A total of 10,715 of the cases reported to the dataset were classified as confirmed cases, and 965 were classified as presumptive. For 187 cases, the status was unknown. 
. For 14 isolates, the species of Legionella was not known.
Category of case
Over the two year period, 748 cases were categorised as nosocomial, 7,328 as community-acquired cases, 1,480 as being associated with travel abroad, 1,030 as associated with travel within the country of residence, 86 as 'other' and 1,195 as 'not known' (Table  4) . In 2008, nosocomial cases were reported in two categories: cases associated with hospitals (n=307) and cases associated with other healthcare premises (n=112). Within countries, the proportion of cases reported to be community-acquired or travel-associated varied to the extent that a north-south divide is apparent, with northern countries having higher rates of travel-associated infections and southern countries higher rates of community-acquired infections. In Denmark, England and Wales and the Netherlands around 40% of cases are acquired as a result of travel abroad, compared with less than 10% for the southern countries France, Italy and Spain where the proportion of travel-associated cases is lower and the majority of these are related to travel within their own country of residence. In contrast, home-acquired community infection is more common in the southern countries where between 65% and 80% of cases fall into this category compared with around 50% for the northern countries specified above.
Travel within Europe accounted for 2,146 (85.5%) of the travel-associated cases over the two years. A more detailed analysis of travel-associated cases of Legionnaires' disease is published each year from EWGLI's surveillance scheme EWGLINET [10] . EWGLINET operates a strict case definition for travel-associated infections (for example excluding patients for whom travel information was incomplete or those for whom travel was outside the 2-10-day incubation period), and so not all cases reported as associated with travel in this dataset can be reported to EWGLINET. Between 2007 and 2008, 2,510 travel cases were reported in the annual dataset, but only 1,795 (71.5%) were reported to EWGLINET (excluding an additional 17 cases that were reported to EWGLINET by countries outside EWGLI).
The month of onset was analysed for those cases that were acquired within the country of residence and reported as community-acquired or associated with travel in their own country. The domestic travel cases followed a similar monthly pattern of onset in both years, although the 2008 cases peaked later (the 2007 peak occurred in July (83 cases), whilst the 2008 peak occurred in August (106 cases)). In contrast, a different pattern was observed across the two years for the community-acquired cases: in 2007 there was a single peak in July (619 cases) mainly accounted for by a large outbreak in Russia (see below), whilst in 2008 there was a double peak, in June (492 cases) and August (486 cases). Table 5 ). The outbreaks ranged in size from two to 130 cases. The largest outbreak in 2007 occurred in Verhnaya Pyshma, Russia (130 cases, five deaths) and was attributed to an interruption of the town's hot water supply [11] [12] . In 2008, the largest outbreak occurred in eastern Spain (21 cases, one death); the source was identified as a cooling tower.
Outbreaks/clusters
Over the two year period, 28 outbreaks (11.5%) involving 98 cases were linked to hospitals or healthcare facilities in Austria, Belgium, Cyprus, Denmark, England and Wales, France, Germany, Ireland, Italy, the Netherlands, Poland and Spain. Twenty-two of these were attributed to hot or cold water systems, one to a wet cooling system and the remaining five could not be attributed to a source. These sources are as reported by our collaborators, and the standard of investigation may vary between countries.
Sixty-three community outbreaks/clusters (25.9%) were identified across the two-year period, involving 417 cases. They occurred in Denmark, England and Wales, France, Ireland, Italy, the Netherlands, Norway, Russia, Spain and Sweden. Sources were identified for 30 (47.6%) of the community outbreaks: wet cooling systems in ten outbreaks, hot or cold water systems in 13, spas in four, a biological treatment plant in one, a footbath in one, and a condensation pipe in one. The source for the remaining 33 could not be identified.
Some 150 clusters (61.7%) were associated with travel, involving 370 cases: 93 with travel outside the country of residence, and 57 with travel within the country of residence. Hot or cold water systems were responsible for 52 of these clusters, a wet cooling system was responsible for one cluster, spa pools for two, and for the remaining 95 the source was unknown. The dataset described here contains only clusters that were detected by individual countries, it does not include clusters that were detected by pooling data across countries (i.e. clusters that comprised single cases from different countries); such clusters are detected by EWGLINET and are reported elsewhere [10] .
In addition, there were two outbreaks associated with private buildings: one in 2007 which was found to be associated with a spa (three cases), and one in 2008 (two cases) for which no source could be identified.
Discussion
The overall number of cases of Legionnaires' disease for 2007-2008 (n=11,867) has remained similar to that of 2005-2006 (n=11,980) . In some countries the number of reported cases remains consistently low, in others it fluctuates due to the unpredictability of large community outbreaks or the seasonal impact of meteorological factors, as has been shown previously in some northern European countries [13] [14] . These fluctuations will also impact on national differences regarding peak months of onset for cases acquired in the community or during domestic travel. Data on month of onset has only been collected in this dataset for two years and, as such, trends cannot yet be determined.
However, the differences in overall trends between countries are usefully highlighted through analyses of these annual datasets and can help to emphasise where improvements in case ascertainment or control and preventive measures can be targeted. The reasons why countries such as Bulgaria, Estonia, Latvia, Lithuania and Romania report fewer than ten cases per year should be urgently reviewed by health officials to assess whether they might benefit from additional laboratory support for diagnosing legionella infections
